2026-01-12 - Analysis Report
**English Report**
================

**Company Overview**
Nike Inc is a multinational corporation that designs, develops, and sells athletic footwear, apparel, equipment, and services.

**Return Rate Comparison**
-------------------------

|  | Rate | Rate_vs | Divergence |
| --- | --- | --- | --- |
| Cumulative Return of Review Stock | -23.51% | -94.03% | -70.52% |
| Divergence (max: 32.10, min: -126.70, current: -117.50, relative divergence: 5.80%) |

**Alpha, Beta Analysis**
------------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|-------|--------|
| 2016-2018 | 11.0% | 19.2% | 7.0% | 1.0 | 109.8B |
| 2017-2019 | 46.0% | 19.2% | 29.0% | 1.1 | 150.0B |
| 2018-2020 | 41.0% | 19.2% | 20.0% | 1.0 | 209.4B |
| 2019-2021 | 55.0% | 17.4% | 12.0% | 1.0 | 246.7B |
| 2020-2022 | -12.0% | 43.4% | -10.0% | 1.1 | 173.2B |
| 2021-2023 | -27.0% | 43.4% | -28.0% | 1.2 | 160.7B |
| 2022-2024 | -67.0% | 37.8% | -87.0% | 1.2 | 112.0B |
| 2023-2025 | -55.0% | 44.0% | -117.0% | 1.0 | 94.3B |

**Recent Stock Price Fluctuations**
------------------------------------

* Close: $65.92
* Last-market: $65.92 ($65.26, $1.01)
* 5-day SMA: $64.86
* 20-day SMA: $63.47
* 60-day SMA: $64.35

**RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**
---------------------------------------------------------------------

* Market Risk Indicator (MRI): 0.70
* RSI: 50.65
* PPO: 0.81
* Recent (20 days) relative divergence change: 0.10 (+)
* 7-day Rank change: 7 (+)
* 7-day Dynamic Expected Return change: 0.50 (+)
* Expected Return: -594.80%

**Recent News & Significant Events**
-----------------------------------

(No concrete analysis will be provided)

**Analyst Opinions**
-------------------

Analyist Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.92 (~Buy)
- Opinions: 33
- Target Price (avg/high/low): 77.00 / 120.00 / 35.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-12-30 | 0.54 | 12.43B$ |
| 2025-10-01 | 0.49 | 11.72B$ |
| 2025-04-03 | 0.54 | 11.27B$ |
| 2025-01-03 | 0.78 | 12.35B$ |
| 2025-12-30 | 0.78 | 12.35B$ |

**Financial Information**
------------------------

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | 12.43B | 40.60% |
| 2025-08-31 | 11.72B | 42.18% |
| 2025-05-31 | 11.10B | 40.27% |
| 2025-02-28 | 11.27B | 41.49% |
| 2024-11-30 | 12.35B | 43.62% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | 14.09B | 5.62% |
| 2025-08-31 | 13.47B | 5.40% |
| 2025-05-31 | 13.21B | 1.60% |
| 2025-02-28 | 14.01B | 5.67% |
| 2024-11-30 | 14.04B | 8.29% |

**Comprehensive Analysis (Summary of previous items)**
---------------------------------------------------

Overall, Nike Inc has shown mixed performance in its stock price and earnings analysis. The company's cumulative return rate is significantly lower than the S&P 500's, indicating a divergence of -70.52% in just the last day of the data. The Alpha and Beta values fluctuated throughout the years, showing a relatively high Beta value of 1.2 in the 2021-2023 period. The RSI is at 50.65, indicating a neutral market condition. The Market Risk Indicator is at 0.70, suggesting a medium level of risk. The Recent Earnings Analysis shows fluctuating EPS and Revenue values, with the company experiencing a 0.54 EPS in the last quarter and Revenue of 12.43B$. The Financial Information table also indicates fluctuations in Revenue and Profit Margin values, with a high Profit Margin of 43.62% in 2024-11-30 and a low Profit Margin of 1.60% in 2025-05-31.

### Sharp Fluctuation 
In regards to the recent fluctuations in the stock price. In the Last-market, $65.92 ($65.26, $1.01). This reflects an increase of 1.01.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.